- Article
Oncotype DX Test Receipt among Latina/Hispanic Women with Early Invasive Breast Cancer in New Jersey: A Registry-Based Study
- Nicholas Acuna,
- Jesse J. Plascak,
- Jennifer Tsui,
- Antoinette M. Stroup and
- Adana A. M. Llanos
12 May 2021
Oncotype DX® (ODX) is a valid test of breast cancer (BC) recurrence risk and chemotherapy benefit. The purpose of this study was to examine prevalence of and factors associated with receipt of ODX testing among eligible Latinas/Hispanics diagnosed wi...